嘉戎技術(301148.SZ):擁有放射性廢水多級濃縮深度處理技術等膜分離應用相關的技術和工藝
格隆匯6月23日丨嘉戎技術(301148.SZ)在互動平台表示,公司主營業務為系列特種膜分離材料及組件、膜分離成套裝備、高性能低温真空蒸發裝備等產品的研發、生產和銷售,以及提供高濃度污廢水處理服務、資源循環回收等。公司擁有放射性廢水多級濃縮深度處理技術等膜分離應用相關的技術和工藝。此前,公司憑藉相關技術優勢,參與核電行業相關項目的招標並實現項目落地。未來,公司也將持續依託多年的膜分離核心技術與應用經驗,進一步深化與核電行業的合作,以滿足市場與環境保護的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.